Grimm Sandra L, Seagroves Tiffany N, Kabotyanski Elena B, Hovey Russell C, Vonderhaar Barbara K, Lydon John P, Miyoshi Keiko, Hennighausen Lothar, Ormandy Christopher J, Lee Adrian V, Stull Malinda A, Wood Teresa L, Rosen Jeffrey M
Department of Molecular and Cellular Biology, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
Mol Endocrinol. 2002 Dec;16(12):2675-91. doi: 10.1210/me.2002-0239.
Targeted deletion of the bZIP transcription factor, CCAAT/enhancer binding protein-beta (C/EBPbeta), was shown previously to result in aberrant ductal morphogenesis and decreased lobuloalveolar development, accompanied by an altered pattern of progesterone receptor (PR) expression. Here, similar changes in the level and pattern of prolactin receptor (PrlR) expression were observed while screening for differentially expressed genes in C/EBPbeta(null) mice. PR patterning was also altered in PrlR(null) mice, as well as in mammary tissue transplants from both PrlR(null) and signal transducer and activator of transcription (Stat) 5a/b-deficient mice, with concomitant defects in hormone-induced proliferation. Down-regulation of PR and activation of Stat5 phosphorylation were seen after estrogen and progesterone treatment in both C/EBPbeta(null) and wild-type mice, indicating that these signaling pathways were functional, despite the failure of steroid hormones to induce proliferation. IGF binding protein-5, IGF-II, and insulin receptor substrate-1 all displayed altered patterns and levels of expression in C/EBPbeta(null) mice, suggestive of a change in the IGF signaling axis. In addition, small proline-rich protein (SPRR2A), a marker of epidermal differentiation, and keratin 6 were misexpressed in the mammary epithelium of C/EBPbeta(null) mice. Together, these data suggest that C/EBPbeta is a master regulator of mammary epithelial cell fate and that the correct spatial pattern of PR and PrlR expression is a critical determinant of hormone-regulated cell proliferation.
先前的研究表明,靶向缺失bZIP转录因子CCAAT/增强子结合蛋白β(C/EBPβ)会导致导管形态发生异常和小叶腺泡发育减少,并伴有孕激素受体(PR)表达模式的改变。在筛选C/EBPβ基因敲除(C/EBPβ(null))小鼠的差异表达基因时,观察到催乳素受体(PrlR)表达水平和模式出现了类似变化。PR的模式在PrlR基因敲除(PrlR(null))小鼠以及来自PrlR基因敲除和信号转导及转录激活因子(Stat)5a/b基因缺陷小鼠的乳腺组织移植中也发生了改变,同时伴有激素诱导的增殖缺陷。在C/EBPβ(null)和野生型小鼠中,雌激素和孕激素处理后均出现PR下调和Stat5磷酸化激活,这表明尽管类固醇激素未能诱导增殖,但这些信号通路仍具有功能。胰岛素样生长因子结合蛋白5(IGF binding protein-5)、胰岛素样生长因子II(IGF-II)和胰岛素受体底物1(insulin receptor substrate-1)在C/EBPβ(null)小鼠中均表现出表达模式和水平的改变,提示IGF信号轴发生了变化。此外,富含脯氨酸的小分子蛋白(SPRR2A)(一种表皮分化标志物)和角蛋白6在C/EBPβ(null)小鼠的乳腺上皮中表达错误。这些数据共同表明,C/EBPβ是乳腺上皮细胞命运的主要调节因子,PR和PrlR表达的正确空间模式是激素调节细胞增殖的关键决定因素。